Alterity Therapeutics Limited (ATHE)
NASDAQ: ATHE · Real-Time Price · USD
2.200
+0.100 (4.76%)
Dec 20, 2024, 4:00 PM EST - Market closed

Alterity Therapeutics Revenue

In the fiscal year ending June 30, 2024, Alterity Therapeutics had annual revenue of 4.02M AUD with 2.63% growth. Alterity Therapeutics had revenue of 2.12M in the half year ending June 30, 2024, a decrease of -23.36%.

Revenue (ttm)
4.02M AUD
Revenue Growth
+2.63%
P/S Ratio
n/a
Revenue / Employee
401,929 AUD
Employees
10
Market Cap
18.30M USD

Revenue Chart

* This company reports financials in AUD.

History

Fiscal Year End Revenue Change Growth
Jun 30, 20244.02M102.95K2.63%
Jun 30, 20233.92M-1.21M-23.56%
Jun 30, 20225.12M783.93K18.06%
Jun 30, 20214.34M--
Jun 30, 2020---
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro
Jun 30, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Flora Growth 64.15M
BioLineRx 21.99M
CervoMed 10.07M
Bolt Biotherapeutics 9.78M
Palatin Technologies 2.38M
Cyclo Therapeutics 870.73K
Revenue Rankings